Halozyme Therapeutics Inc. Common Stock vs Tower Semiconductor Ltd. Ordinary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Tower Semiconductor Ltd. Ordinary Shares trades at $228.71 (market cap $27.04B). The key difference: Tower Semiconductor Ltd. Ordinary Shares is far larger — about 2.1× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Tower Semiconductor Ltd. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Tower Semiconductor Ltd. Ordinary Shares for 1 Days on average.
| HALO | TSEM | |
|---|---|---|
Market Cap | $12.58B | $27.04B |
Volume | 2,179,278 | 2,436,902 |
Sector | Health | Technology |
52-Week High | $115.22 | $316.85 |
52-Week Low | $61.63 | $71.11 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $25.71B |
Trailing returns across standard periods
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Tower Semiconductor is a specialty semiconductor foundry that manufactures analog and mixed-signal chips for other companies.
Read more on TSEM →